Tahithromos’s Mead Johnson Nutrition Company MJN Stock Holding History

Tahithromos’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-27,500	Closed	-$2.17M	–	21
2015 Q4	$2.17M	Sell	27,500 -27,500	-50%	-$2.17M	2.06%	12
2015 Q3	$3.87M	Hold	55,000	–	–	3.6%	8
2015 Q2	$4.96M	Hold	55,000	–	–	6.82%	5
2015 Q1	$5.53M	Hold	55,000	–	–	2.56%	14
2014 Q4	$5.53M	Hold	55,000	–	–	2.65%	15
2014 Q3	$5.29M	Hold	55,000	–	–	1.37%	23
2014 Q2	$5.12M	Hold	55,000	–	–	1.22%	24
2014 Q1	$4.57M	Buy	55,000 +5,000	+10%	+$405K	1.1%	23
2013 Q4	$4.19M	Buy	50,000 +20,000	+67%	+$1.63M	0.94%	29
2013 Q3	$2.23M	Buy	+30,000	New	+$2.25M	0.38%	53

Other funds holding MJN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Tahithromos's MJN Position: Q1 2016 in Review

Tahithromos sold out of Mead Johnson Nutrition Company (MJN) in Q1 2016, closing a stake of 27,500 shares — an estimated $2.17M sold.

Tahithromos first reported a position in MJN in Q3 2013 and held it in 10 quarters. The position peaked at $5.53M in Q4 2014. 562 funds tracked by Wall St. Rank hold MJN as of Q1 2016.

Tahithromos reported no remaining Mead Johnson Nutrition Company position as of Q1 2016 after selling out during the quarter.
Tahithromos sold 27,500 Mead Johnson Nutrition Company shares in Q1 2016, an estimated $2.17M.
Tahithromos first reported a position in Mead Johnson Nutrition Company in Q3 2013 and held it in 10 quarters.
Tahithromos's Mead Johnson Nutrition Company position peaked at $5.53M in Q4 2014.
562 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2016.

Based on Tahithromos's 13F filing for Q1 2016, filed 5 May 2016.